Inflectra®—Biosimilar for Remicade (infliximab)
Written by: Ketki Gupte | Last reviewed: September 2019
- FDA approves Inflectra, a biosimilar to Remicade. US Food and Drug Administration. April 5, 2016. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm494227.htm. Accessed June 9, 2018.
Prescribing Information. Hospira, a Pfizer Company. Lake Forest, IL. Published April 2016.
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125544s000lbl.pdf Accessed June 9, 2018. Medication Guide. Hospira, a Pfizer Company, Lake Forest, IL. Revised April 2016. https://www.fda.gov/downloads/Drugs/DrugSafety/UCM497384.pdf Accessed June 9, 2018.
- INFLECTRA-infliximab-dyyb injection, powder, lyophilized, for solution. DailyMed. US National Library of Medicine. National Institutes of Health. Bethesda, MD. Updated November 21, 2017. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=37eaca10-d812-48bc-8b8e-b836bfa9968f Accessed June 10, 2018.